This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Basilea Pharmaceutica International Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Martin Stieger: Innovator in Pharmaceutical Chemistry
Introduction
Martin Stieger is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Stieger holds a patent for "Substituted mono- and polyazanaphthalene derivatives and their use." This patent discloses various compounds that are useful in treating proliferation disorders or diseases, such as cancer. The compounds are characterized by complex chemical structures that include various functional groups, making them versatile in their applications.
Career Highlights
Martin Stieger is associated with Basilea Pharmaceutica International AG, where he has been instrumental in advancing research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the creation of new therapeutic agents.
Collaborations
Stieger collaborates with esteemed colleagues, including Jens Pohlmann and Stefan Reinelt. These partnerships enhance the research capabilities and innovation potential within the company.
Conclusion
Martin Stieger's contributions to pharmaceutical chemistry and his innovative patent work underscore his role as a key figure in the industry. His efforts continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile